The Lancet

When to and when not to use machine learning in risk prediction models

Machine learning for health data science, fuelled by proliferation of data and reduced computational costs, has garnered ...
News-Medical.Net

High-content analysis software for advanced image insights

Yokogawa’s high-content analysis software combines machine learning, 3D image analysis, and label-free imaging to deliver ...
ascopubs.org

Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?

Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician? The following represents disclosure information provided by authors of this ...
Morningstar

Machine Learning Can Forecast Which Stock Factors Will Outperform

A recent study, “Picking Winners in Factorland: A Machine Learning Approach to Predicting Factor Returns,” set out to answer a critical question: Can machine learning techniques improve the prediction ...
The Manila Times

2026 Data Science Course Created by FAANG+ Data Scientists Focused on Production-Ready Skills in AI and Machine Learning

SANTA CLARA, CA, Feb. 12, 2026 (GLOBE NEWSWIRE) -- SANTA CLARA, CA - February 12, 2026 - - ...
National Academies of Sciences%2c Engineering%2c and Medicine

Making Machine Learning Safer in High-Stakes Settings

Machine learning, a key enabler of artificial intelligence, is increasingly used for applications like self-driving cars, medical devices, and advanced robots that work near humans — all contexts ...

AI Patent Eligibility Has Shifted With One Machine-Learning Case

Opinion: A patent case involving inventor Guillaume Desjardins has evolved into a cornerstone of modern patent eligibility practice for AI technologies in just four months.
ascopubs.org

Reply to: Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?

Erratum: Randomized Comparison of Intensified Six-Drug Versus Standard Three-Drug Chemotherapy for High-Risk Nonmetastatic Rhabdomyosarcoma and Other Chemotherapy-Sensitive Childhood Soft Tissue ...